AusPAR: Dolutegravir sodium / Abacavir sulfate / Lamivudine

Australian Public Assessment Report

AusPAR

AusPAR: Dolutegravir sodium/Abacavir sulfate/Lamivudine [PDF, 803.76 KB]

AusPAR: Dolutegravir sodium/Abacavir sulfate/Lamivudine [DOCX, 660.41 KB]

Attachment: Product information: Dolutegravir sodium/Abacavir sulfate/Lamivudine [PDF, 384.15 KB]

Attachment: Product information: Dolutegravir sodium/Abacavir sulfate/Lamivudine [DOCX, 138.02 KB]

Attachment: Extract from the Clinical Evaluation Report: Dolutegravir sodium/Abacavir sulfate/Lamivudine [PDF, 13.2 MB]

Attachment: Extract from the Clinical Evaluation Report: Dolutegravir sodium/Abacavir sulfate/Lamivudine [DOCX, 8.73 MB]

Device/Product Name

Triumeq

Active ingredients

Dolutegravir sodium / Abacavir sulfate / Lamivudine

AusPAR Date

19 May 2015

Published

16 July 2015

Submission Number

PM-2013-04112-1-2

Submission Type

New fixed dose combination

Decision

Approved

Product types

Prescription medicines